| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243459 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 6 Pages |
Abstract
Conclusion: High-dose-rate-EBBT achieved a long-term cause-specific survival rate of 50% of the patients with localized endobronchial carcinoma and could be considered curative.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christophe M.D., Ph.D., Olivier M.D., Jean M.D., Laurent M.D., Guillaume M.D., Gérard M.D., Ph.D., Claude M.D.,